L-DOPA and Droxidopa: From Force Field Development to Molecular Docking into Human β(2)-Adrenergic Receptor

The increasing interest in the molecular mechanism of the binding of different agonists and antagonists to [Formula: see text] (2)-adrenergic receptor ([Formula: see text] (2)AR) inactive and active states has led us to investigate protein–ligand interactions using molecular docking calculations. To...

Descripción completa

Detalles Bibliográficos
Autores principales: Catte, Andrea, Biswas, Akash Deep, Mancini, Giordano, Barone, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501711/
https://www.ncbi.nlm.nih.gov/pubmed/36143429
http://dx.doi.org/10.3390/life12091393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501711/
https://www.ncbi.nlm.nih.gov/pubmed/36143429
http://dx.doi.org/10.3390/life12091393

Ejemplares similares